NCT03868046 2025-04-01
AUTENTIC
Hospital Universitario Araba
Completed
Clinical Trials
8 trialsNCT03881137 2022-11-09
Improved Function and Quality of Life for Older Patients Receiving Radiotherapy, Part II
Sykehuset Innlandet HF
Phase NA Completed
NCT03154671 2022-05-20
Comprehensive Geriatric Assessment and Management for Canadian Elders With Cancer
University of Toronto
Phase NA Completed
NCT04095000 2021-08-09
FACE-TC-Sp
Children's National Research Institute
Phase NA Completed
NCT02132845 2021-02-04
Next Generation Sequence Target-Directed Therapy in Treating Patients With Cancer
Fox Chase Cancer Center
Phase NA Completed
NCT02943174 2019-05-30
MIND Programme for Cancer Patients
University of Coimbra
Phase NA Completed
NCT02587819 2016-04-14
Investigation of the Safety and Tolerability of BSCT (Anti-nf-P2X7) 10% Ointment
Biosceptre
Phase 1 Completed
NCT00874042 2012-07-23
Dose Escalation Study of ARQ 197 in Combination With Gemcitabine in Adult Patients With Advanced Solid Tumors
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Phase 1 Completed